Super-Responders in Moderate–Severe Psoriasis under Guselkumab Treatment: Myths, Realities and Future Perspectives by Ricardo Ruiz-Villaverde, Fiorella Vasquez-Chinchay, Lourdes Rodriguez-Fernandez-Freire, Jose C. Armario-Hita, Amalia Pérez-Gil, Manuel Galán-Gutiérrez

Get full text

Effectiveness, survival and safety of guselkumab attending to basal characteristics in moderate-to-severe psoriatic patients: a cohort study [version 2; peer review: 2 approved] by Fiorella Vasquez Chinchay, Manuel Galán-Gutiérrez, Jose C. Armario-Hita, Amalia Pérez-Gil, Ricardo Ruiz-Villaverde, Lourdes Rodriguez-Fernandez-Freire

Get full text

Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi‐Criteria Decision Analysis by Juan Francisco Silvestre, M. J. Tribó, José C. Armario‐Hita, Miguel Ángel Calleja‐Hernández, Francisco Javier Ortiz‐Frutos, José Luis Poveda, John Shepherd, Esther Serra‐Baldrich

Get full text

Clinical Approach to Patients with Moderate-to-Severe Atopic Dermatitis: A Spanish Delphi Consensus by Jose J. Pereyra-Rodriguez, Esther S. Baldrich, Ricardo Ruiz-Villaverde, Eulalia B. Torres, Pablo de la C. Dobao, Ignasi F. Nart, Ángeles F. Menéndez, Ana Martin-Santiago, Javier M. Miquel, Juan F. Silvestre, Jose C. Armario-Hita

Get full text